Flonoltinib 75mg

DRUG3 trials

Sponsors

Chengdu Zenitar Biomedical Technology Co., Ltd

Conditions

MBMFPolycythemia Vera (PV)

Phase 1

Mass Balance Study of [14C] Flonoltinib Maleate

CompletedNCT07612306

Chengdu Zenitar Biomedical Technology Co., LtdMB

Start: 2026-07-06End: 2026-07-31Updated: 2026-08-13

Phase 2

Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

RecruitingNCT07232290

Chengdu Zenitar Biomedical Technology Co., LtdPolycythemia Vera (PV)

Start: 2025-09-23End: 2028-02-28Target: 60Updated: 2026-08-14

Phase 3

A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis

RecruitingNCT07317700

Chengdu Zenitar Biomedical Technology Co., LtdMF

Start: 2026-02-13End: 2028-03-30Target: 105Updated: 2026-08-13